Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.
Xiao-Dong ZhouSeung-Up KimTerry Cheuk Fung YipSalvatore PettaAtsushi NakajimaEmmanuel TsochatzisJérôme BoursierElisabetta BugianesiHannes HagströmWah-Kheong ChanManuel RomeroJose Luis CallejaVictor de LédinghenLaurent CastéraArun J SanyalGeorge Boon-Bee GohPhilip Noel NewsomeJiangao FanMichelle LaiCéline Fournier-PoizatHye-Won LeeGrace Lai-Hung WongAngelo ArmandiYing ShangGrazia PennisiElba LlopMasato YonedaMarc de Saint-LoupClémence M CanivetCarmen Lara-RomeroRocio Gallego-DurànAmon AsgharpourKevin Kim-Jun TehSara MahgoubMandy Sau-Wai ChanHuapeng LinWen-Yue LiuGiovanni TargherChristopher D ByrneVincent Wai-Sun WongMing-Hua Zhengnull nullPublished in: Gut (2024)
Statin usage was associated with a relatively lower long-term risk of all-cause mortality, LREs and liver stiffness progression in patients with MASLD.